Search Results 931-940 of 2087 for 搜索引擎平台开发咨询邮箱:lgooxc@hotmail.com
The Genetics, Epigenetics and Metabolomics Core at Mayo Clinic offers six main PKD services for research and tools for polycystic kidney disease.
About this study. The purpose of this study is helping researchers evaluate the pharmacokinetics (how the body handles a drug), safety, and tolerability of ...
See Mayo Clinic Center for Clinical and Translational Science (CCaTS) Innovation in Clinical Trial Design Award goals, eligibility, funding and application ...
A Phase 2, Multi-center, Open-label Study to Evaluate the Efficacy and Safety of Luspatercept (ACE-536) in Subjects with Myeloproliferative Neoplasm-Associated ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of NB003 in subjects with Advanced Solid Tumors. Participation eligibility.
The performance characteristics of these assays for detecting ctDNA mutation in oncology patients will be assessed by comparing the mutation results obtained ...
The overarching goal of this research project is to understand causal factors associated with arthrofibrosis risk, severity and subsequent need for manipulation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.